Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Additional Paid In Capital Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Additional Paid In Capital
kr12.5B
CAGR 3-Years
2%
CAGR 5-Years
9%
CAGR 10-Years
6%
Zealand Pharma A/S
CSE:ZEAL
Additional Paid In Capital
kr14.7B
CAGR 3-Years
52%
CAGR 5-Years
48%
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genmab A/S's Additional Paid In Capital?
Additional Paid In Capital
12.5B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Additional Paid In Capital amounts to 12.5B DKK.

What is Genmab A/S's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
6%

Over the last year, the Additional Paid In Capital growth was 1%. The average annual Additional Paid In Capital growth rates for Genmab A/S have been 2% over the past three years , 9% over the past five years , and 6% over the past ten years .

Back to Top